MEDAMI 2014 - III MEDITERRANEAN THEMATIC WORKSHOP IN ADVANCED MOLECULAR IMAGING

Session

KEY NOTE SESSION 2

3 Sept 2014, 14:30

Hotel Portoconte

Conveners

KEY NOTE SESSION 2

• York Haemisch (Philips)

76. PET Radiotracer Discovery and Development for Neuroimaging

Roger Gunn (Imperial College)

03/09/2014, 14:30

The discovery and development of a successful CNS radiotracer is challenging and is akin to a mini drug discovery and development process itself, although with a different set of criteria (e.g. fast clearance and low bioavailability are not good for drugs but are often ideal for radioligands). Key parameters guiding tractability have previously centered on labeling feasibility, lipophilicity...

77. PET Neuroimaging in Early Phase Drug Development

Roger Gunn (Imperial College)

03/09/2014, 15:00

The discovery and development of central nervous system (CNS) drugs is a complex task that requires large investments of time and money with no guarantee of success. Currently it is estimated that it costs around €1 billion to bring each successful drug to market. Imaging techniques, such as positron emission tomography (PET), can provide important information by taking direct biological...

78. The role of medical imaging in pharmaceutical industry

Nicholas Seneca (Roche)

03/09/2014, 15:30

79. The role of equipment industry in the translation from research ideas into medical (imaging) devices - a personal view

York Haemisch

03/09/2014, 16:00

This talk will try to determine stimulating and hindering factors in the translation of research ideas and projects into new medical imaging devices. The focus will be on ideas originating from the particle physics/detector research community applied to isotope based imaging. Recent and past examples of successful and failed projects will be discussed with a special attention to the respective...